NICOX (EPA:COX) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
NICOX

PRESS RELEASE

published on 09/04/2025 at 07:30, 5 months 3 days ago

Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed
Nicox expects to fully repay financial debts in 2026 with NCX 470 de-risked and globally licensed, providing a financial update and strategic options. Milestones payable on NDA submissions and approvals

Strategic Options Nicox NCX 470 Financial Debts NDA Submissions
BRIEF

published on 08/26/2025 at 07:35, 5 months 12 days ago

Nicox launches FAQ page for shareholders

Shareholders Transparency Ophthalmology Nicox FAQ
PRESS RELEASE

published on 08/26/2025 at 07:30, 5 months 12 days ago

Nicox Announces Shareholder Q&A Webpage Available
Nicox introduces Q&A webpage for shareholders on nicox.com, addressing common queries about the company and its operations. Contact communications@nicox.com for investor queries

Shareholders Ophthalmology Nicox Q&A Webpage Investor Questions
BRIEF

published on 08/12/2025 at 15:58, 5 months 26 days ago

Soleus Capital Crosses Threshold in NICOX

Voting Rights Actions Threshold Crossing Nicox Soleus Capital
BRIEF

published on 08/08/2025 at 07:35, 5 months 30 days ago

Nicox Expands Equity Financing with Vester Finance

Equity Financing Nicox Share Dilution Phase 3 Results Vester Finance
PRESS RELEASE

published on 08/08/2025 at 07:30, 5 months 30 days ago

Nicox Extends Existing Flexible Equity Financing
Nicox extends PACEO equity line with Vester Finance by adding 5 million shares. NCX 470 Denali Phase 3 results expected in mid-August to mid-September 2025

Equity Financing Nicox Phase 3 Results NCX 470 Denali Vester Finance
BRIEF

published on 06/30/2025 at 07:35, 7 months 7 days ago

Nicox Achieves Milestone in NCX 470 Phase 3 Clinical Trial

Glaucoma Ocular Hypertension Phase 3 Trial Nicox NCX 470
PRESS RELEASE

published on 06/30/2025 at 07:30, 7 months 7 days ago

Nicox Announces Last Patient Completes the NCX 470 Denali Phase 3 Clinical Trial
Nicox announces completion of Denali Phase 3 trial for NCX 470 eye drop, expecting results mid-August to mid-September 2025. NDA submission in the U.S. targeted for H1 2026

Phase 3 Trial Ophthalmology Nicox NCX 470 NDA Submission
BRIEF

published on 06/06/2025 at 07:35, 8 months 1 day ago

Nicox Announces Shareholders’ Meeting and Ad Hoc Representative

Voting Rights Shareholders’ Meeting Euronext Growth Nicox Ad Hoc Representative
PRESS RELEASE

published on 06/06/2025 at 07:30, 8 months 1 day ago

Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 27, 2025 and appointment of an ad hoc representative
Nicox SA announces Ordinary and Extraordinary Shareholders' Meeting on June 27, 2025, appoints ad hoc representative. Details on agenda, proxy voting, and meeting participation

Shareholders' Meeting Proxy Voting Nicox SA Ad Hoc Representative Meeting Participation

Accesswire

Published on 02/07/2026 at 01:00, 1 day 2 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 4 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 5 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 12 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 14 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 6 hours 38 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 11 hours 3 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 11 hours 18 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 8 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 9 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 9 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 11 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 8 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 9 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 9 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE